Repository logo

Statistics for Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant: a study based on molecular docking, molecular dynamics, MM/PBSA and MM/GBSA

Total visits

views
Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant: a study based on molecular docking, molecular dynamics, MM/PBSA and MM/GBSA 30

Total visits per month

views
July 2024 2
August 2024 2
September 2024 3
October 2024 2
November 2024 2
December 2024 6
January 2025 0

File Visits

views
Naringenin-4'-glucuronide as a new drug candidate against the COVID-19 Omicron variant_a study based on molecular docking, molecular dynamics.pdf(legacy) 1

Top country views

views
United States 10
China 7
Australia 5
Portugal 4
Brazil 1
Canada 1
India 1
Mongolia 1